Celldex Therapeutics Inc. (CLDX)
NASDAQ: CLDX
· Real-Time Price · USD
24.98
0.04 (0.16%)
At close: Aug 15, 2025, 12:34 PM
Celldex Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.79M | 7.56M | 7.02M | 9.98M | 8.3M | 6.07M | 6.88M | 4.37M | 3.25M | 3.15M | 2.36M | 1.08M | 823K | 4.14M | 4.65M | 8.1M | 8.62M | 5.38M |
Cost of Revenue | 1.6M | 2.4M | 3.18M | 3.12M | 3.1M | 3.06M | 3.01M | 2.92M | 23.73M | 23.71M | 40.04M | 54.05M | 46.03M | 57.65M | 53.31M | 38.63M | 35.78M | 33.13M |
Gross Profit | 4.97M | 5.94M | 4.63M | 7.64M | 5.2M | 3.02M | 3.88M | 1.44M | -20.47M | -20.56M | -37.69M | -52.97M | -45.21M | -53.51M | -48.66M | -30.53M | -27.17M | -27.76M |
Operating Income | -234.75M | -217.21M | -195.08M | -186.68M | -175.79M | -162.68M | -154.54M | -134.8M | -121.26M | -124.45M | -115.23M | -107.69M | -100.82M | -77.86M | -71.24M | -75.68M | -69.2M | -67.13M |
Interest Income | 35.14M | 38.36M | 37.22M | 32.6M | 25.57M | 17.8M | 10M | 5.68M | 2.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -199.61M | -178.85M | -157.86M | -154.08M | -150.22M | -144.88M | -141.43M | -124.61M | -113.13M | -118.64M | -112.33M | -105.99M | -99.88M | -77.25M | -70.74M | -73.43M | -66.97M | -64.86M |
Net Income | -199.61M | -178.85M | -157.86M | -154.08M | -150.22M | -144.88M | -134.48M | -114.87M | -103.39M | -125.46M | -124.61M | -121.06M | -114.73M | -75.54M | -70.51M | -72.26M | -66.03M | -63.69M |
Selling & General & Admin | 41.53M | 40.27M | 38.55M | 37.12M | 35.28M | 33.38M | 30.91M | 28.68M | 26.99M | 26.92M | 27.19M | 26.84M | 26.13M | 23.28M | 20.49M | 17.87M | 15.69M | 14.91M |
Research & Development | 152.93M | 137.63M | 115.9M | 99.45M | 133.98M | 121.34M | 117.25M | 110.48M | 97.52M | 92M | 82.26M | 74.04M | 66.02M | 57.65M | 53.31M | 49.06M | 46.21M | 43.56M |
Other Expenses | 45.26M | 45.26M | 45.26M | 45.26M | -767K | 25.47M | 25.47M | 25.47M | 26.24M | 8.67M | 25.16M | 25.16M | 26.76M | 30.68M | 27.39M | 27.39M | 37.15M | 24.56M |
Operating Expenses | 239.72M | 223.15M | 199.71M | 181.82M | 168.5M | 153.95M | 147.4M | 138.4M | 124.51M | 118.92M | 109.45M | 100.87M | 92.15M | 80.93M | 73.8M | 66.93M | 61.9M | 58.47M |
Interest Expense | n/a | n/a | n/a | 3.11M | 3.11M | 3.11M | 3.11M | n/a | n/a | n/a | n/a | n/a | 2.91M | 2.91M | 2.91M | 28.06M | 25.15M | 25.15M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 240.54M | 224.77M | 202.1M | 196.65M | 184.09M | 168.75M | 161.43M | 139.16M | 124.51M | 118.92M | 109.45M | 100.87M | 92.15M | 80.93M | 73.8M | 66.93M | 61.9M | 58.47M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -6.95M | -9.74M | -9.74M | 6.82M | 12.28M | 15.08M | 14.85M | -1.71M | -227K | -1.17M | -939K | -1.17M |
Shares Outstanding (Basic) | 66.39M | 66.38M | 66.35M | 66.29M | 66.02M | 58.87M | 52.03M | 47.26M | 47.25M | 47.21M | 47.13M | 46.92M | 46.76M | 46.74M | 46.58M | 45.45M | 39.33M | 39.38M |
Shares Outstanding (Diluted) | 66.39M | 66.38M | 66.35M | 66.29M | 66.02M | 58.87M | 52.03M | 47.26M | 47.25M | 47.21M | 47.13M | 46.92M | 46.76M | 46.74M | 46.69M | 45.45M | 39.62M | 39.61M |
EPS (Basic) | -3.01 | -2.7 | -2.45 | -2.57 | -2.74 | -2.85 | -2.76 | -2.43 | -2.19 | -2.66 | -2.65 | -2.58 | -2.46 | -1.68 | -1.64 | -1.76 | -1.67 | -1.83 |
EPS (Diluted) | -3.01 | -2.7 | -2.45 | -2.57 | -2.74 | -2.85 | -2.76 | -2.43 | -2.19 | -2.66 | -2.65 | -2.58 | -2.46 | -1.68 | -1.64 | -1.76 | -1.67 | -1.83 |
EBITDA | -231.4M | -213.94M | -191.9M | -171.06M | -160.19M | -147.12M | -139.03M | -131.88M | -118.43M | -112.96M | -104.2M | -96.8M | -88.24M | -73.68M | -66.08M | -55.78M | -50.13M | -49.56M |
EBIT | -234.75M | -217.21M | -195.08M | -174.18M | -163.29M | -150.18M | -142.04M | -134.8M | -121.26M | -115.77M | -107.1M | -99.8M | -91.33M | -76.78M | -69.15M | -58.83M | -53.28M | -53.1M |
Depreciation & Amortization | 3.35M | 3.27M | 3.18M | 3.12M | 3.1M | 3.06M | 3.01M | 2.92M | 2.83M | 2.81M | 2.9M | 3M | 3.08M | 3.1M | 3.07M | 3.05M | 3.15M | 3.54M |